Cleared Traditional

K000343 - NAC Y-ADP

K000343 is an FDA 510(k) clearance for NAC Y-ADP, manufactured by The Kipp Group. The device is a Class 2 General Hospital device with product code FPA cleared through the Traditional 510(k) pathway after a 27-day FDA review.

K000343 · The Kipp Group · General Hospital
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Mar 2000
Decision
27d
Days
Class 2
Risk

K000343 is an FDA 510(k) clearance for the NAC Y-ADP. Classified as Set, Administration, Intravascular (product code FPA), Class II - Special Controls.

Submitted by The Kipp Group (Ontario, US). The FDA issued a Cleared decision on March 1, 2000 after a review of 27 days - a notably fast clearance cycle.

This device falls under the General Hospital FDA review panel, regulated under 21 CFR 880.5440 - the FDA general hospital device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all The Kipp Group devices

FDA 510(k) Submission Details - K000343

510(k) Number K000343 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received February 03, 2000
Decision Date March 01, 2000
Days to Decision 27 days
Submission Type Traditional
Review Panel General Hospital (HO)
Summary Statement
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
102d faster than avg
Panel avg: 129d · This submission: 27d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

FPA Device Classification - Class 2, Special Controls

Product Code FPA Set, Administration, Intravascular
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 880.5440
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most General Hospital devices follow this clearance model.

Regulatory Peers - FPA Set, Administration, Intravascular

All 645
Devices cleared under the same product code (FPA) and FDA review panel - the closest regulatory comparables to K000343.
LIFESHIELD ADDITIVE PIERCING PIN
K002006 · Abbott Laboratories · Aug 2000
POSI-LINK
K000472 · Icu Medical, Inc. · May 2000
CADD CHECKVALVE ADMINISTRATION SET, MODEL 21-7090
K000942 · Sims Deltec, Inc. · Apr 2000
EXEL INJECTION PLUG WITH CAP
K992290 · Exel Intl. · Feb 2000
BOLUS ACCESSORY SET
K992072 · I-Flow Corp. · Sep 1999
SOF-SET MICRO QR INFUSION SET, MODELS 320 AND 321
K991979 · Medtronic Minimed · Sep 1999